Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies

Nomura, S. (2016). Advances in Diagnosis and Treatments for Immune Thrombocytopenia. Clinical Medicine Insights: Blood Disorders, (2016), 15-22. https://doi.org/10.4137/CMBD.S39643
Tepie, M. A. F., Roux, G. L., Beach, K. J., Bennett, D., & Robinson, N. J. (2009). Comorbidities of Idiopathic Thrombocytopenic Purpura: A Population-Based Study. Advances in Hematology, 2009(), 145-156. https://doi.org/10.1155/2009/963506
Hsiao, J. F., Chu, C. M., Chung, C. M., Chang, S. T., Kuo, C. T., & Hsu, J. T. (2008). Prognostic Significance of Thrombocytopenia in Acute Pulmonary Embolism. 內科學誌, 19(6), 499-507. https://doi.org/10.6314/JIMT.2008.19(6).07
Wang, K. L., Kao, Y. T., Chang, W. T., Chang, H. Y., Huang, W. C., Hsu, P. C., Hsu, C. H., Huang, C. L., Hsieh, L. C., Wang, C. Y., Lin, Y. H., Lin, T. H., Chiu, K. M., Hwang, J. J., & Chu, P. H. (2020). Management of Venous Thromboembolisms: Part II. The Consensus for Pulmonary Embolism and Updates. Acta Cardiologica Sinica, 36(6), 562-582. https://doi.org/10.6515/ACS.202011_36(6).20200917A
Wang, K. L., & Chu, P. H. (2021). Management of Venous Thromboembolisms: Part II. The Consensus for Pulmonary Embolism and Updates. Acta Cardiologica Sinica, 37(2), 215-216. https://doi.org/10.6515/ACS.202103_37(2).20210120A